Cat. No. | Product Name | CAS No. | Information |
---|---|---|---|
CSN24892 | Usnic acid | 125-46-2 | Usnic acid is a furandione found uniquely in lichen that is used widely in cosmetics, deodorants, toothpaste and medicinal creams as well as some herbal products. It exhibits antiviral, antiprotozoal, antiproliferative, anti-inflammatory and analgesic activity. |
CSN27234 | NDMC101 | 1308631-40-4 | NDMC101 is a potent osteoclastogenesis inhibitor and inhibits osteoclast differentiation via down-regulation of NFATc1-modulated gene express. NDMC101 is similar to the DPP4 substrate and is a significant inhibitor of early T-cell activation via DPP4 inhibition. NDMC101can be used for study of bone disorders, such as rheumatoid arthritis, and synovial inflammation et al . |
CSN11214 | Ipriflavone | 35212-22-7 | Ipriflavone is a synthetic isoflavone derivative used to prevent and treat osteoporosis. |
CSN12493 | Ibandronate | 114084-78-5 | Ibandronic acid is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis. |
CSN12541 | Ibandronate sodium monohydrate | 138926-19-9 | Ibandronate sodium is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis. |
CSN11938 | Ibandronate Sodium | 138844-81-2 | Ibandronate sodium is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis. |
CSN11706 | Glycitin | 40246-10-4 | Glycitin, a natural isoflavone, could promote the proliferation of bone marrow stromal cells and osteoblasts and protect the loss of bone. It can be isolated and purified from legumes. |
CSN18130 | Evatanepag | 223488-57-1 | Evatanepag is an EP2 receptor selective prostaglandin E2 PGE2 agonist that induces local bone formation with EC50 of 03 nM |
CSN13980 | Emodin-8-glucoside | 23313-21-5 | Emodin-8-beta-D-glucoside, a natural product isolated and purified from the root and rhizome of Rheum palmatum L., functions to protect from focal cerebral injury induced by ischemia and reperfusion and directly stimulates cell proliferation and differentiation of osteoblasts. |
CSN25419 | Bropirimine | 56741-95-8 | Bropirimine is a synthetic agonist for toll-like receptor 7 (TLR7). Bropirimine inhibits differentiation of osteoclast precursor cells into osteoclasts via TLR7-mediated production of IFN-β. Bropirimine is an orally active immunomodulator that has demonstrated anticancer activity in transitional cell carcinoma in situ (CIS) in both the bladder and upper urinary tract. |